Haemonetics Appoints Anila Lingamneni Executive Vice President, Chief Technology Officer
Lingamneni will oversee Haemonetics' Innovation Agenda and lead the Company's research, development, software, and medical and clinical affairs. As Chief Technology Officer, she will be responsible for advancing technologies and product investments that support the Company's business units and align with growth strategies including software as a service (SaaS) and digital.
"Anila's deep experience in medical device product ideation, development, launch and lifecycle management will strengthen our R&D organization and invigorate our teams as we continue to drive innovative customer- and patient-focused solutions," said Simon. "Our Innovation Agenda is a critical value driver for Haemonetics and reinforces our commitment to meaningfully advancing healthcare with both transformational and sustaining technology developments. We are excited to welcome Anila to Haemonetics."
Before joining Haemonetics, Lingamneni was Vice President, Renal R&D, at Baxter International, where she was responsible for the product portfolio delivering renal therapy solutions to dialysis patients, including devices, software, disposables and fluids. In this role, she led a globally distributed team of engineers and scientists to drive long-term product roadmap definition and therapy innovation and delivered critical product launches. Lingamneni previously served as Vice President, Device Engineering, where she was responsible for all electromechanical devices and software applications for Baxter's medical device portfolio, including infusion systems, compounding systems, renal peritoneal and hemodialysis systems and acute renal therapy systems. Before joining Baxter, Lingamneni held several roles at
Lingamneni received a Bachelor of Science in Electrical and Electronics Engineering and a Master of Science in Mathematics from
About Haemonetics
Investor Contact: |
Media Contact: |
|
|
(781) 356-9763 |
(781) 348-7263 |
View original content to download multimedia:http://www.prnewswire.com/news-releases/haemonetics-appoints-anila-lingamneni-executive-vice-president-chief-technology-officer-301031997.html
SOURCE